• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN LLC ENDURANT II STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN LLC ENDURANT II STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR Back to Search Results
Model Number UNK-CV-SR-ENDUR-II
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Fistula (1862); Hemorrhage/Blood Loss/Bleeding (1888); Perforation of Vessels (2135); Rupture (2208); Obstruction/Occlusion (2422)
Date of Event 02/13/2025
Type of Reportable Event Serious Injury
Event or Problem Description
Literature was reviewed regarding ¿ expanding the evar pool with non-ifu patients: how important is subjective physician assessment?¿.The time frame of this study was over a five-year period.A total of 248 patients underwent evar with a cohort of the study population outside the stent grafts instructions for use (ifu).Endurant ii and non-mdt stent grafts were implanted in the patient population.The following adverse events occurred: occlusion, blood loss, fistula, rupture, perforation, intervention no further information was provided pertaining to medtronic products.
 
Additional Manufacturer Narrative
Medtronic received the following information from a journal article entitled; ¿expanding the evar pool with non-ifu patients: how important is subjective physician assessment?¿.Iner h, yurekli i, karaagac e, peker i, tunca nu, tellioglu tm, durmaz h, selcuk ho, yilik l journal of clinical medicine.2025; 14(4):1237.Https://doi.Org/10.3390/jcm14041237 medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
Manufacturer (Section D)
COVIDIEN LLC
15 hampshire st
mansfield MA 02048
Manufacturer (Section G)
COVIDIEN LLC
15 hampshire st
mansfield MA 02048
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key22077863
Report Number1282497-2025-00348
Device Sequence Number15312264
Product Code MIH
Combination Product (Y/N)N
Initial Reporter CountryTU
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Literature,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 05/23/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberUNK-CV-SR-ENDUR-II
Device Catalogue NumberUNK-CV-SR-ENDUR-II
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/21/2025
Initial Report FDA Received Date05/23/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age70 YR
Patient SexMale
-
-